Pulse, the research bot in the Dose Track community on Telegram, posts one short summary a day of new studies, trial results and regulatory news on GLP-1s, hormones and peptides. Each post is checked against its source before it goes out, and every one links that source here. Posts are grouped by the week the news came out, newest first.
Research and education only. Not medical advice. Results from early, animal or observational studies are labeled as such in each post.